ACADIA Pharmaceuticals Inc. (ACAD) Social Stream
ACADIA PHARMACEUTICALS INC (ACAD) Price Targets From Analysts
Use the tables below to see what analysts covering ACADIA PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 17 | $35 | $18 | $25.125 | $31.31 | -19.75% |
| 2021-12-07 | 17 | $35 | $18 | $25.562 | $31.31 | -18.36% |
| 2021-12-08 | 18 | $35 | $18 | $26.562 | $31.31 | -15.16% |
| 2021-12-09 | 18 | $39 | $18 | $27.235 | $31.31 | -13.02% |
| 2021-12-21 | 18 | $39 | $18 | $27.588 | $31.31 | -11.89% |
| 2021-12-22 | 19 | $42 | $18 | $28.944 | $31.31 | -7.56% |
| 2022-01-28 | 19 | $42 | $18 | $28.944 | $31.31 | -7.56% |
| 2022-02-09 | 19 | $42 | $20 | $29.944 | $31.31 | -4.36% |
| 2022-03-02 | 19 | $42 | $20 | $29.777 | $31.31 | -4.9% |
| 2022-03-10 | 19 | $42 | $20 | $30.055 | $31.31 | -4.01% |
| 2022-04-03 | 19 | $42 | $20 | $30.111 | $31.31 | -3.83% |
| 2022-04-19 | 18 | $42 | $20 | $30.111 | $31.31 | -3.83% |
| 2022-04-26 | 18 | $42 | $20 | $30.166 | $31.31 | -3.65% |
| 2022-05-06 | 18 | $42 | $20 | $29.833 | $31.31 | -4.72% |
| 2022-06-08 | 18 | $42 | $20 | $29.882 | $31.31 | -4.56% |
| 2022-06-15 | 17 | $42 | $20 | $29.882 | $31.31 | -4.56% |
| 2022-06-16 | 17 | $42 | $20 | $30.058 | $31.31 | -4% |
| 2022-06-21 | 17 | $42 | $20 | $29.411 | $31.31 | -6.07% |
| 2022-08-01 | 17 | $42 | $10 | $24.437 | $31.31 | -21.95% |
| 2022-08-02 | 17 | $42 | $10 | $24.117 | $31.31 | -22.97% |
| 2022-08-05 | 17 | $42 | $10 | $24 | $31.31 | -23.35% |
| 2022-08-08 | 17 | $42 | $10 | $23.062 | $31.31 | -26.34% |
| 2022-08-09 | 19 | $42 | $10 | $22.411 | $31.31 | -28.42% |
| 2022-08-10 | 19 | $42 | $10 | $21.294 | $31.31 | -31.99% |
| 2022-09-17 | 19 | $42 | $10 | $20.764 | $31.31 | -33.68% |
| 2022-10-03 | 18 | $42 | $10 | $20.764 | $31.31 | -33.68% |
| 2022-10-13 | 18 | $42 | $10 | $20.647 | $31.31 | -34.06% |
| 2022-10-21 | 17 | $42 | $10 | $20.647 | $31.31 | -34.06% |
| 2022-11-01 | 18 | $42 | $10 | $20.444 | $31.31 | -34.7% |
| 2022-11-04 | 19 | $42 | $10 | $20.388 | $31.31 | -34.88% |
| 2022-11-07 | 19 | $42 | $10 | $20.333 | $31.31 | -35.06% |
| 2022-11-15 | 19 | $42 | $10 | $20.222 | $31.31 | -35.41% |
| 2022-12-13 | 18 | $42 | $10 | $20.222 | $31.31 | -35.41% |
| 2022-12-21 | 18 | $25 | $10 | $18.25 | $31.31 | -41.71% |
| 2023-01-03 | 18 | $25 | $10 | $18.47 | $31.31 | -41.01% |
| 2023-01-25 | 18 | $25 | $10 | $18.529 | $31.31 | -40.82% |
| 2023-01-27 | 18 | $25 | $10 | $18.529 | $31.31 | -40.82% |
| 2023-01-30 | 18 | $27 | $10 | $18.647 | $31.31 | -40.44% |
| 2023-01-31 | 18 | $27 | $10 | $18.764 | $31.31 | -40.07% |
| 2023-02-08 | 18 | $25 | $10 | $18.705 | $31.31 | -40.26% |
| 2023-02-13 | 18 | $27 | $10 | $18.823 | $31.31 | -39.88% |
| 2023-02-27 | 18 | $27 | $10 | $18.882 | $31.31 | -39.69% |
| 2023-02-28 | 19 | $28 | $10 | $19.729 | $31.31 | -36.99% |
| 2023-03-01 | 19 | $28 | $10 | $20.022 | $31.31 | -36.05% |
| 2023-03-03 | 19 | $28 | $10 | $20.188 | $31.31 | -35.52% |
| 2023-03-06 | 19 | $28 | $10 | $20.3 | $31.31 | -35.16% |
| 2023-03-13 | 19 | $28 | $10 | $20.633 | $31.31 | -34.1% |
| 2023-03-14 | 19 | $33 | $12 | $21.688 | $31.31 | -30.73% |
| 2023-05-09 | 18 | $33 | $12 | $22.244 | $31.31 | -28.96% |
| 2023-05-10 | 18 | $33 | $12 | $22.244 | $31.31 | -28.96% |
| 2023-05-19 | 18 | $33 | $12 | $22.422 | $31.31 | -28.39% |
| 2023-06-06 | 18 | $33 | $12 | $22.588 | $31.31 | -27.86% |
| 2023-06-15 | 18 | $36 | $12 | $23.588 | $31.31 | -24.66% |
| 2023-07-11 | 17 | $36 | $12 | $24.152 | $31.31 | -22.86% |
| 2023-07-14 | 17 | $36 | $12 | $24.447 | $31.31 | -21.92% |
| 2023-07-17 | 17 | $42 | $12 | $27.8 | $31.31 | -11.21% |
| 2023-07-28 | 17 | $42 | $12 | $28.882 | $31.31 | -7.75% |
| 2023-08-03 | 17 | $42 | $12 | $29.411 | $31.31 | -6.07% |
| 2023-08-14 | 17 | $42 | $12 | $29.47 | $31.31 | -5.88% |
| 2023-10-08 | 17 | $42 | $12 | $30.062 | $31.31 | -3.99% |
| 2023-10-10 | 17 | $42 | $12 | $30.25 | $31.31 | -3.39% |
| 2023-10-17 | 17 | $42 | $12 | $30.125 | $31.31 | -3.78% |
| 2023-11-03 | 17 | $42 | $13 | $31.187 | $31.31 | -0.39% |
| 2023-11-06 | 17 | $42 | $13 | $31.375 | $31.31 | 0.21% |
| 2023-12-13 | 17 | $42 | $13 | $31.312 | $31.31 | 0.01% |
| 2023-12-18 | 17 | $42 | $13 | $31.437 | $31.31 | 0.41% |
| 2023-12-27 | 17 | $42 | $13 | $32.125 | $31.31 | 2.6% |
| 2023-12-29 | 18 | $42 | $13 | $32.588 | $31.31 | 4.08% |
The Trend in the Analyst Price Target
Over the past 44 months, ACAD's average price target has gone down $26.41.
ACAD reports an average of 6.75% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-28 | 19 | 28 | 10 | 19.058 | 20.690 | -7.89% |
| 2023-07-17 | 17 | 42 | 12 | 28.764 | 33.465 | -14.05% |
| 2023-09-26 | 17 | 42 | 12 | 30.062 | 23.630 | 27.22% |
| 2023-10-17 | 17 | 42 | 13 | 31.187 | 23.400 | 33.28% |
| 2023-11-06 | 17 | 42 | 13 | 31.375 | 23.980 | 30.84% |
ACAD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.83 | 11 | 1 | 5 | 1 | 1 | 18 |
The Trend in the Broker Recommendations
Over the past 18 months, ACAD's average broker recommendation rating improved by 0.12.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ACADIA PHARMACEUTICALS INC's number of analysts covering the stock is greater than 7831.57% of them.
- In terms of how ACADIA PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 539.95% of that group.
- In terms of how ACADIA PHARMACEUTICALS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -6794.85% of that group.
- ACADIA PHARMACEUTICALS INC's average analyst price target is higher than 2868.72% of stocks in the mid market cap category.
Stocks similar to ACADIA PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTCT, DVAX, and OPK.
View All Top Stocks by Price Target
Make investment decisions regarding ACAD using the data that counts. Try POWR Ratings for free.